title: Cyberknife treatment for low and intermediate risk prostate cancer.
abstract: Cyberknife is an emerging treatment for early stage prostate cancer. Between October 2012 and January 2014, 32 patients were treated in our institution. Prescribed dose was 35-36.25 Gy in five fractions. Biochemical response was observed in 22 patients. Four patients experienced G2 acute genitourinary toxicity and in two cases we recorded G3 acute GU toxicity. 5 patients experienced G2 acute proctitis. At last follow up visit, all patients were still alive. 29 remained free of disease at last follow up appointment, while three developed a biochemical recurrence. Our experience confirms the efficacy and safety of Cyberknife for localized prostate cancer.
authors.affiliation: 1Radiotherapy Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence , Florence , Italy.
authors.forename: B
authors.initials: B
authors.lastname: Detti
authors.forename: P
authors.initials: P
authors.lastname: Bonomo
authors.forename: L
authors.initials: L
authors.lastname: Masi
authors.forename: R
authors.initials: R
authors.lastname: Doro
authors.forename: S
authors.initials: S
authors.lastname: Cipressi
authors.forename: C
authors.initials: C
authors.lastname: Iermano
authors.forename: I
authors.initials: I
authors.lastname: Bonucci
authors.forename: D
authors.initials: D
authors.lastname: Franceschini
authors.forename: V
authors.initials: V
authors.lastname: Di Cataldo
authors.forename: L
authors.initials: L
authors.lastname: Di Brina
authors.forename: M
authors.initials: M
authors.lastname: Baki
authors.forename: G
authors.initials: G
authors.lastname: Simontacchi
authors.forename: I
authors.initials: I
authors.lastname: Meattini
authors.forename: M
authors.initials: M
authors.lastname: Carini
authors.forename: S
authors.initials: S
authors.lastname: Serni
authors.forename: G
authors.initials: G
authors.lastname: Nicita
authors.forename: L
authors.initials: L
authors.lastname: Livi
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011467:Prostate / Q000473:pathology / Q000601:surgery; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery*; D011832:Radiation Injuries; D016634:Radiosurgery; D065287:Robotic Surgical Procedures
keywords: Cyberknife; Prostate cancer; Radiation oncology